On 28th November OxTalks will move to the new Halo platform and will become 'Oxford Events' (full details are available on the Staff Gateway).
There will be an OxTalks freeze beginning on Friday 14th November. This means you will need to publish any of your known events to OxTalks by then as there will be no facility to publish or edit events in that fortnight. During the freeze, all events will be migrated to the new Oxford Events site. It will still be possible to view events on OxTalks during this time.
If you have any questions, please contact halo@digital.ox.ac.uk
Dr Ricardo Fernandes is a Group Leader at the CAMS Oxford Institute and Nuffield Department of Medicine at the University of Oxford. He holds a PhD from Oxford, where he worked with Simon Davis to elucidate the mechanism of TCR triggering. Later, he moved to Stanford, where he developed innovative bispecific proteins that utilize endogenous membrane phosphatases to inhibit signalling by surface receptors found in T cells. The Fernandes’ Lab focuses on elucidating the functional and structural aspects of immune receptor signalling and identifying novel therapeutic strategies for modulating T cell function in the context of autoimmunity and cancer.
